HK Stock MarketDetailed Quotes

JUNSHI BIO (01877)

Watchlist
  • 24.300
  • -0.580-2.33%
Trading May 14 14:56 CST
24.95BMarket Cap-35.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JUNSHI BIO (01877) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
45.09%726.29M
28.23%2.5B
42.06%1.81B
48.64%1.17B
31.46%500.59M
29.67%1.95B
28.87%1.27B
17.37%786.06M
49.24%380.8M
3.38%1.5B
Operating income
45.09%726.29M
28.23%2.5B
42.06%1.81B
48.64%1.17B
31.46%500.59M
29.67%1.95B
28.87%1.27B
17.37%786.06M
49.24%380.8M
3.38%1.5B
Cost of sales
----
-4.79%-522.76M
----
-15.92%-244.36M
----
25.24%-498.86M
----
26.94%-210.8M
----
-26.79%-667.29M
Operating expenses
-56.52%-146.98M
-4.79%-522.76M
-7.42%-349.48M
-15.92%-244.36M
13.13%-93.9M
25.24%-498.86M
3.42%-325.34M
26.94%-210.8M
-26.41%-108.09M
-26.79%-667.29M
Gross profit
42.45%579.31M
36.30%1.98B
53.98%1.46B
60.63%924.03M
49.13%406.69M
73.53%1.45B
45.60%945.86M
50.91%575.26M
60.76%272.71M
-9.92%835.26M
Selling expenses
-11.56%-251.77M
-6.95%-1.05B
-12.38%-768.28M
-13.98%-487.34M
-17.79%-225.68M
-16.60%-984.55M
-23.31%-683.63M
-14.59%-427.55M
-4.91%-191.59M
-17.98%-844.36M
Administrative expenses
-42.89%-138.64M
5.11%-519.74M
12.27%-309.9M
17.35%-208.76M
21.32%-97.02M
1.63%-547.71M
1.71%-353.24M
-4.39%-252.6M
-8.99%-123.31M
3.71%-556.81M
Research and development expenses
19.42%-282.5M
-8.52%-1.38B
-12.34%-982.15M
-36.34%-744.93M
-26.89%-350.58M
34.18%-1.28B
31.19%-874.27M
42.40%-546.38M
47.64%-276.29M
18.74%-1.94B
Profit from asset sales
-97.66%176.91K
----
-56.19%5.65M
----
-68.18%7.55M
----
2,047.14%12.89M
----
--23.72M
----
Revaluation surplus
-4,519.79%-13.36M
----
293.04%58.02M
----
74.95%-289.23K
----
34.45%-30.05M
----
81.15%-1.15M
----
-Changes in the fair value of other assets
-4,519.79%-13.36M
----
293.04%58.02M
----
74.95%-289.23K
----
34.45%-30.05M
----
81.15%-1.15M
----
Impairment and provision
-257.22%-11.51M
-82.97%3.36M
-1,037.67%-70.63M
-77.33%2.36M
-135.75%-3.22M
184.00%19.73M
120.72%7.53M
1,028.34%10.42M
143.94%9.01M
-49,865.96%-23.48M
-Other impairment is provision
-257.22%-11.51M
-82.97%3.36M
-1,037.67%-70.63M
-77.33%2.36M
-135.75%-3.22M
184.00%19.73M
120.72%7.53M
1,028.34%10.42M
143.94%9.01M
-49,865.96%-23.48M
Special items of operating profit
3,560.50%131.7M
176.96%181.98M
-89.51%3.2M
979.08%92.61M
-106.55%-3.81M
-48.04%65.71M
621.45%30.46M
-84.30%8.58M
-105.13%-1.84M
-28.30%126.46M
Operating profit
102.67%7.27M
37.48%-795.7M
35.03%-624.73M
33.25%-422.04M
7.50%-272.32M
46.98%-1.27B
41.21%-961.58M
44.00%-632.28M
54.58%-294.39M
6.77%-2.4B
Financing income
-0.21%7.39M
----
-31.33%22.42M
----
-46.93%7.41M
----
-57.94%32.65M
----
-50.83%13.96M
----
Financing cost
-42.72%-23.99M
-45.61%-74.77M
-51.55%-49.88M
-58.64%-38.7M
-43.85%-16.81M
-77.04%-51.35M
-64.76%-32.91M
-67.67%-24.39M
-39.08%-11.68M
1.24%-29.01M
Share of profits of associates
----
-184.39%-62.07M
----
27.50%-14.03M
----
60.64%-21.83M
----
36.04%-19.35M
----
20.19%-55.45M
Share of profit from joint venture company
----
-309.31%-54.03M
----
-25.96%-11.18M
----
-162.39%-13.2M
----
-331.60%-8.88M
----
-224.58%-5.03M
Special items of earning before tax
-80.71%-9.25M
----
-37.44%-21.33M
----
-37.90%-5.12M
----
42.83%-15.52M
----
12.32%-3.71M
----
Earning before tax
86.81%-37.84M
27.41%-986.57M
29.68%-692.39M
29.05%-485.95M
3.28%-286.84M
45.42%-1.36B
38.75%-984.64M
41.75%-684.89M
53.48%-296.55M
6.93%-2.49B
Tax
----
161.55%13.88M
----
650.21%19.54M
----
48.74%-22.55M
----
-107.03%-3.55M
----
-147.25%-44M
After-tax profit from continuing operations
83.27%-43.43M
29.60%-972.69M
31.80%-674.31M
32.25%-466.41M
13.37%-259.59M
45.48%-1.38B
36.42%-988.73M
38.82%-688.45M
53.15%-299.65M
1.87%-2.53B
Earning after tax
83.27%-43.43M
29.60%-972.69M
31.80%-674.31M
32.25%-466.41M
13.37%-259.59M
45.48%-1.38B
36.42%-988.73M
38.82%-688.45M
53.15%-299.65M
1.87%-2.53B
Minority profit
7.48%-22.86M
-32.87%-131.78M
-26.88%-78.61M
-23.91%-52.98M
-48.69%-24.71M
60.68%-99.18M
58.22%-61.96M
66.84%-42.75M
82.72%-16.62M
-28.68%-252.26M
Profit attributable to shareholders
91.24%-20.56M
34.43%-840.91M
35.72%-595.7M
35.97%-413.43M
17.01%-234.88M
43.79%-1.28B
34.12%-926.77M
35.20%-645.69M
47.92%-283.03M
4.38%-2.28B
Basic earnings per share
91.67%-0.02
35.38%-0.84
36.17%-0.6
36.36%-0.42
17.24%-0.24
43.97%-1.3
34.27%-0.94
34.65%-0.66
47.27%-0.29
10.77%-2.32
Diluted earnings per share
91.67%-0.02
35.38%-0.84
36.17%-0.6
36.36%-0.42
17.24%-0.24
43.97%-1.3
34.27%-0.94
34.65%-0.66
47.27%-0.29
10.77%-2.32
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Rongcheng Certified Public Accountants (Special General Partnership)
--
--
--
Huapu Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Huapu Tianjian Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover 45.09%726.29M28.23%2.5B42.06%1.81B48.64%1.17B31.46%500.59M29.67%1.95B28.87%1.27B17.37%786.06M49.24%380.8M3.38%1.5B
Operating income 45.09%726.29M28.23%2.5B42.06%1.81B48.64%1.17B31.46%500.59M29.67%1.95B28.87%1.27B17.37%786.06M49.24%380.8M3.38%1.5B
Cost of sales -----4.79%-522.76M-----15.92%-244.36M----25.24%-498.86M----26.94%-210.8M-----26.79%-667.29M
Operating expenses -56.52%-146.98M-4.79%-522.76M-7.42%-349.48M-15.92%-244.36M13.13%-93.9M25.24%-498.86M3.42%-325.34M26.94%-210.8M-26.41%-108.09M-26.79%-667.29M
Gross profit 42.45%579.31M36.30%1.98B53.98%1.46B60.63%924.03M49.13%406.69M73.53%1.45B45.60%945.86M50.91%575.26M60.76%272.71M-9.92%835.26M
Selling expenses -11.56%-251.77M-6.95%-1.05B-12.38%-768.28M-13.98%-487.34M-17.79%-225.68M-16.60%-984.55M-23.31%-683.63M-14.59%-427.55M-4.91%-191.59M-17.98%-844.36M
Administrative expenses -42.89%-138.64M5.11%-519.74M12.27%-309.9M17.35%-208.76M21.32%-97.02M1.63%-547.71M1.71%-353.24M-4.39%-252.6M-8.99%-123.31M3.71%-556.81M
Research and development expenses 19.42%-282.5M-8.52%-1.38B-12.34%-982.15M-36.34%-744.93M-26.89%-350.58M34.18%-1.28B31.19%-874.27M42.40%-546.38M47.64%-276.29M18.74%-1.94B
Profit from asset sales -97.66%176.91K-----56.19%5.65M-----68.18%7.55M----2,047.14%12.89M------23.72M----
Revaluation surplus -4,519.79%-13.36M----293.04%58.02M----74.95%-289.23K----34.45%-30.05M----81.15%-1.15M----
-Changes in the fair value of other assets -4,519.79%-13.36M----293.04%58.02M----74.95%-289.23K----34.45%-30.05M----81.15%-1.15M----
Impairment and provision -257.22%-11.51M-82.97%3.36M-1,037.67%-70.63M-77.33%2.36M-135.75%-3.22M184.00%19.73M120.72%7.53M1,028.34%10.42M143.94%9.01M-49,865.96%-23.48M
-Other impairment is provision -257.22%-11.51M-82.97%3.36M-1,037.67%-70.63M-77.33%2.36M-135.75%-3.22M184.00%19.73M120.72%7.53M1,028.34%10.42M143.94%9.01M-49,865.96%-23.48M
Special items of operating profit 3,560.50%131.7M176.96%181.98M-89.51%3.2M979.08%92.61M-106.55%-3.81M-48.04%65.71M621.45%30.46M-84.30%8.58M-105.13%-1.84M-28.30%126.46M
Operating profit 102.67%7.27M37.48%-795.7M35.03%-624.73M33.25%-422.04M7.50%-272.32M46.98%-1.27B41.21%-961.58M44.00%-632.28M54.58%-294.39M6.77%-2.4B
Financing income -0.21%7.39M-----31.33%22.42M-----46.93%7.41M-----57.94%32.65M-----50.83%13.96M----
Financing cost -42.72%-23.99M-45.61%-74.77M-51.55%-49.88M-58.64%-38.7M-43.85%-16.81M-77.04%-51.35M-64.76%-32.91M-67.67%-24.39M-39.08%-11.68M1.24%-29.01M
Share of profits of associates -----184.39%-62.07M----27.50%-14.03M----60.64%-21.83M----36.04%-19.35M----20.19%-55.45M
Share of profit from joint venture company -----309.31%-54.03M-----25.96%-11.18M-----162.39%-13.2M-----331.60%-8.88M-----224.58%-5.03M
Special items of earning before tax -80.71%-9.25M-----37.44%-21.33M-----37.90%-5.12M----42.83%-15.52M----12.32%-3.71M----
Earning before tax 86.81%-37.84M27.41%-986.57M29.68%-692.39M29.05%-485.95M3.28%-286.84M45.42%-1.36B38.75%-984.64M41.75%-684.89M53.48%-296.55M6.93%-2.49B
Tax ----161.55%13.88M----650.21%19.54M----48.74%-22.55M-----107.03%-3.55M-----147.25%-44M
After-tax profit from continuing operations 83.27%-43.43M29.60%-972.69M31.80%-674.31M32.25%-466.41M13.37%-259.59M45.48%-1.38B36.42%-988.73M38.82%-688.45M53.15%-299.65M1.87%-2.53B
Earning after tax 83.27%-43.43M29.60%-972.69M31.80%-674.31M32.25%-466.41M13.37%-259.59M45.48%-1.38B36.42%-988.73M38.82%-688.45M53.15%-299.65M1.87%-2.53B
Minority profit 7.48%-22.86M-32.87%-131.78M-26.88%-78.61M-23.91%-52.98M-48.69%-24.71M60.68%-99.18M58.22%-61.96M66.84%-42.75M82.72%-16.62M-28.68%-252.26M
Profit attributable to shareholders 91.24%-20.56M34.43%-840.91M35.72%-595.7M35.97%-413.43M17.01%-234.88M43.79%-1.28B34.12%-926.77M35.20%-645.69M47.92%-283.03M4.38%-2.28B
Basic earnings per share 91.67%-0.0235.38%-0.8436.17%-0.636.36%-0.4217.24%-0.2443.97%-1.334.27%-0.9434.65%-0.6647.27%-0.2910.77%-2.32
Diluted earnings per share 91.67%-0.0235.38%-0.8436.17%-0.636.36%-0.4217.24%-0.2443.97%-1.334.27%-0.9434.65%-0.6647.27%-0.2910.77%-2.32
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Rongcheng Certified Public Accountants (Special General Partnership)------Huapu Tianjian Certified Public Accountants (Special General Partnership)------Huapu Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +3.21%
Sample Name
Sample Code
 +2.36%
4
CNOOC
00883
+0.92%
5
SINOPEC CORP
00386
+0.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +44.26%
Sample Name
Sample Code
 +31.66%
4
Loongson Technology Corporation
688047
+21.36%
5
Digital China Group
000034
+18.07%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -